Average Co-Inventor Count = 4.42
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (8 from 3,684 patents)
2. Exelixis, Inc. (1 from 175 patents)
3. Bristol Meyers Squibb Company (1 from 41 patents)
4. Avalon Pharmaceuticals, Inc. (1 from 3 patents)
11 patents:
1. 8124729 - Splice variants of human G-protein coupled receptor HGPRBMY29 (HGPRMBY29SV2)
2. 7635758 - Antibodies directed to G-protein coupled receptor HGPRBMY29sv1
3. 7427473 - Chemo-centric selection of disease-related genetic profiles
4. 7345148 - Human G-protein coupled receptor, HGPRBMY29sv1 polypeptides
5. 7304141 - Human leucine-rich repeat containing protein expressed predominately in bone marrow, HLRRBM1
6. 7276354 - Polynucleotides encoding a novel human G-protein coupled receptor splice variant, HGPRBMY29SV2
7. 7265260 - Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors
8. 7223557 - Polynucleotide encoding a TRP channel family member, TRP-PLIK2
9. 7049088 - PRMTs as modifiers of the p53 pathway and methods of use
10. 7049096 - Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1
11. 6534531 - Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy